Keyphrases
Placebo
100%
Obsessive-compulsive Disorder
100%
Pharmaceutics
100%
Sustained Response
100%
Selective Serotonin Reuptake Inhibitors
50%
Acute Treatment
33%
Escitalopram
33%
Paroxetine
33%
Relapse Prevention
33%
Clomipramine
33%
Meta-analysis
16%
Randomized Controlled Trial
16%
Long-term Treatment
16%
Targeted Treatment
16%
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
16%
Treatment Trials
16%
Fluoxetine
16%
Placebo-controlled Trial
16%
Adult Treatment
16%
Prevention Trials
16%
Sertraline
16%
Extended Treatment
16%
Review Manager
16%
Treatment Responder
16%
Long-term Relapse
16%
Re-emergence
16%
Scale Points
16%
Long-term Medication
16%
Medicine and Dentistry
Placebo
100%
Obsessive Compulsive Disorder
100%
Drug Therapy
42%
Selective Serotonin Reuptake Inhibitor
42%
Relapse Prevention
28%
Escitalopram
28%
Clomipramine
28%
Paroxetine
28%
Randomized Controlled Trial
14%
Meta-Analysis
14%
Sertraline
14%
Yale-Brown Obsessive Compulsive Scale
14%
Fluoxetine
14%
Neuroscience
Obsessive-Compulsive Disorder
100%
Placebo
100%
Selective Serotonin Reuptake Inhibitor
42%
Escitalopram
28%
Paroxetine
28%
Clomipramine
28%
Relapse Prevention
28%
Meta-Analysis
14%
Randomized Controlled Trial
14%
Fluoxetine
14%
Sertraline
14%
Treatment of Obsessive-Compulsive Disorder
14%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Obsessive Compulsive Disorder
100%
Selective Serotonin Reuptake Inhibitor
42%
Escitalopram
28%
Paroxetine
28%
Clomipramine
28%
Randomized Controlled Trial
14%
Fluoxetine
14%
Sertraline
14%